Dr. Stephen G. Odaibo is a practicing retina specialist, a mathematician, computer scientist, software engineer, certified professional cloud cybersecurity engineer, and biochemist. During his medical training, he spent two years in the laboratory of Dr. Robert J. Lefkowitz. There, he worked closely with Dr. Lefkowitz who went on to win the 2012 Nobel Prize in Chemistry for elucidating the role of G-Protein Coupled Receptors as targets for drug therapies.
Dr. Odaibo founded Deep EigenMatics in February 2025 to build cutting edge AI tools that will revolutionize the drug discovery pipeline, and generate novel effective therapies for patients. Prior to that, in 2024, he authored `The Foundational Mathematics of Artificial Intelligence,’ a 400 page textbook about the mathematical nuts and bolts of AI. So far in 2025 alone, Dr. Odaibo has filed 15 U.S. patent applications for AI-based protein and drug design methods of which four have already received a Notice of Allowance or Allowability from the USPTO.
Dr. Odaibo is also Founder and CEO of RETINA-AI Health, Inc., a company focused on building AI-powered value-based care technologies for early detection of chronic disease. RETINA-AI Health, Inc. conducted the largest ever pivotal clinical trial for an autonomous AI-system, the RETINA-AI Galaxy™ for diabetic retinopathy detection. Dr. Odaibo is an expert on medical device software development and regulatory/quality. He has chaired the Medical Device Software Development Summit every year since 2022. He holds multiple patents for AI-based Diabetic Retinopathy detection.
Dr. Odaibo Obtained his B.S. and M.S. degrees in Mathematics from the University of Alabama Birmingham, his M.S. in Computer Science from Duke University, and his M.D. degree from Duke University School of Medicine where he won the Barrie Hurwitz Award for Excellence in Clinical Neurology. Dr. Odaibo performed his Prelim in Internal Medicine at Duke University Hospital, Ophthalmology residency at Howard University, and Fellowship in Medical Retina, Uveitis, and Ocular Oncology at the University of Michigan Kellogg Eye Center in Ann Arbor. He serves on the Industry Advisory Board of the Duke University Master of Engineering in Artificial Intelligence Program, and on the Advisory Board of Data Science Nigeria. Dr. Odaibo has been on the Faculty at Duke University, University of Michigan, University of Houston, and the MD Anderson Cancer Center.
He loves spending time with his wife, Dr. Lisa Odaibo, a pediatrician, and their four young children.